Personalized medicine: a world of opportunities in skin diseases
I Al-Hoqail
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorR Salem
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorM Monshi
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorC Zeilinger
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorV Zimmerman
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorCorresponding Author
A Zaher
* Corresponding author, Department of Medical Basic Sciences, Faculty of Medicine, King Fahad Medical City, PO Box 59046, Riyadh, Saudi Arabia, tel. +9661 288 9999, ext. 5767; fax +9661 463 4487; E-mail: [email protected]Search for more papers by this authorI Al-Hoqail
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorR Salem
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorM Monshi
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorC Zeilinger
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorV Zimmerman
Faculty of Medicine and Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia
Search for more papers by this authorCorresponding Author
A Zaher
* Corresponding author, Department of Medical Basic Sciences, Faculty of Medicine, King Fahad Medical City, PO Box 59046, Riyadh, Saudi Arabia, tel. +9661 288 9999, ext. 5767; fax +9661 463 4487; E-mail: [email protected]Search for more papers by this authorDOI: 10.1111/j.1468-3083.2008.02651.x
References
- 1 Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med 2005; 352: 2211–2221.
- 2 Nihal Ahmad N, Mukhtar H. Cytochrome P450: a target for drug development for skin diseases. J Invest Dermatol 2004; 123: 417–425.
- 3 US FDA. Summary minutes of the Clinical Pharmacology Subcommittee Meeting of the Advisory Committee for Pharmaceutical Science. Rockville, MD, 14–15 November 2005.
- 4 Baron JM, Holler D, Schiffer R et al . Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 2001; 116: 541–548.
- 5 Herceptin [package insert]. South San Francisco. Genentech, Inc, CA, 2006.
- 6 Camptosar [package insert]. Pfizer Inc, New York, NY, 2006.
- 7 Du L, Hoffman SM, Keeney DS. Epidermal CYP2 family cytochromes P450. Toxicol Appl Pharmacol 2004; 195: 278.
- 8 Janmohamed A, Dolphin CT, Phillips IR, Shephard EA. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol 2001; 62: 777–786.
- 9 Accutane [package insert]. Roche Laboratories, Nutley, NJ, 2005.
- 10 Khaled A, Zeglaoui F, Zoghlami A, Fazaa B, Kamoun MR. Dissecting cellulitis of the scalp: response to isotretinoin. J Eur Acad Dermatol Venereol 2007; 21: 1430–1431.
- 11
Van Durme DJ.
Common dermatoses. In: Taylor RB
(senior Ed.), AK David,
SA Fields,
DM Phillips,
JE Scherger, eds. Family Medicine: Principles and Practice, 6th edn. Springer-Verlag, New York, NY, 2003: 980–990.
10.1007/978-0-387-21744-4_115 Google Scholar
- 12 Oracea [package insert]. CardinalHealth, Winchester, KY, 2006.
Citing Literature
